Blood Glucose Monitoring Devices Market to grow by USD 7,488.81 million during 2023-2027; The rising global burden of diabetes to drive the market growth

NEW YORK, May 29, 2023 /PRNewswire/ — The blood glucose monitoring devices market is set to grow by USD 7,488.81 mn from 2023 to 2027 progressing at a CAGR of 8.88% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.

The blood glucose monitoring devices market covers the following areas:

Blood Glucose Monitoring Devices Market Sizing
Blood Glucose Monitoring Devices Market Forecast
Blood Glucose Monitoring Devices Market Analysis

The market is driven by rising global burden of diabetes. Diabetes is a chronic disease which is characterized by high blood sugar levels. Blood glucose meters are used by diabetics to track their blood sugar levels and adjust their treatment plans accordingly. There is growing awareness among healthcare professionals and patients to maintain tight glycemic control to prevent diabetes-related complications such as kidney disease, blindness, and cardiovascular disease. 

Here is an Exclusive report talking about Market scenarios with a historical period (2017-2021) and forecast period (2023-2027). Download Sample Report in minutes!

The report on the blood glucose monitoring devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. 

Blood Glucose Monitoring Devices Market 2023-2027 – Market Dynamics

Market Trends

Use of smart watch-based apps is trending in this market: Smart watch-based apps are increasingly used in this market to monitor and track various activities such as heart rate, sleep, physical activity, and other health metrics. These apps use CGM sensors to measure the level of glucose in the user’s interstitial fluid.

Users can monitor their glucose levels without the requirement to carry a separate device or prick their fingers to take a blood sample. This makes it easier for diabetics to manage their condition and maintain good blood sugar control. This helps the patients to take proactive steps for controling their glucose levels, such as dietary adjustments or medication.

Market Challenges

Stringent regulatory framework is causing a challenge in this market: Regulatory bodies and agencies such as the US FDA and the European Medicines Agency (EMA) have strict rules and regulations for medical devices to conduct extensive clinical trials which increase operational costs, and delay new product launches, thus hindering market growth during the forecast period.

Blood Glucose Monitoring Devices Market 2023-2027 : Market Segmentation

The blood glucose monitoring devices market analysis includes end-user, product, and geography landscape. This study identifies the smart watch-based apps, increasing adoption of home healthcare devices, and increased adoption of bundled product marketing strategy as the prime reasons driving the blood glucose monitoring devices market growth during the next few years.

The market share growth will be driven by the hospitals segment during the forecast period. Hospitals use blood glucose meters to treat diabetes in patients, monitor blood glucose levels during surgery, and monitor critically ill patients who are at risk of high or low blood sugar levels. 

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters- View Sample Report

Companies Mentioned

• Abbott Laboratories
• Ascensia Diabetes Care Holdings AG
• Bigfoot Biomedical Inc.
• Dexcom Inc.
• DiaMonTech AG
• F. Hoffmann La Roche Ltd.
• GlySens Inc.
• Health Arx Technologies Pvt. Ltd.
• Insulet Corp.
• Level2 Medical Services P.A.
• Levels Health Inc.
• Medtronic Plc
• Medtrum Technologies Inc.
• Novo Nordisk AS
• PKvitality S.A.S.
• Sanofi SA
• Senseonics Holdings Inc.
• SFC Fluidics Inc.
• Teladoc Health Inc.
• Ypsomed AG

Vendor Offerings

• Abbott Laboratories – The company offers blood glucose monitoring bgm devices such as FreeStyle Libre.
• Ascensia Diabetes Care Holdings AG – The company offers a range of blood glucose monitoring systems such as CONTOUR NEXT Blood Glucose Monitoring Systems, CONTOUR PLUS Blood Glucose Monitoring Systems, and Diabetes Management Solutions.
• Dexcom Inc. – The company offers blood glucose monitoring bgm devices such as G6 and G7.

Related Reports:

The non-invasive glucose monitoring devices market is estimated to grow at a CAGR of 15.68% between 2022 and 2027. The size of the market is forecast to increase by USD 22.49 million.This report extensively covers market segmentation by product (wearable and non-wearable), end-user (home care settings, hospitals, and clinics), and geography (North America, Europe, Asia, and Rest of World (ROW)). The increasing prevalence of diabetes and the growing number of government programs are notably driving the market growth, although factors such as high costs associated with non-invasive glucose monitoring devices may impede the market growth.

The continuous glucose monitoring (CGM) market is estimated to grow at a CAGR of 6.37% between 2022 and 2027. The size of the market is forecast to increase by USD 2,588.61 million. This report extensively covers market segmentation by component (sensors, transmitters, and receivers), end-user (home care, hospitals, and others), and geography (North America, Europe, Asia, and Rest of World). The rise in the diabetic population is notably driving the CGM market growth.

Gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Key Topics Covered:

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global blood glucose monitoring devices market 2017 – 2021 
• Exhibit 18: Historic Market Size – Data Table on global blood glucose monitoring devices market 2017 – 2021 ($ million)

• 4.2 End-user Segment Analysis 2017 – 2021
• Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)

• 4.3 Product Segment Analysis 2017 – 2021
• Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments 
• Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)

• 6.2 Comparison by End-user 
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user

• 6.3 Hospitals – Market size and forecast 2022-2027
• Exhibit 34: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)

• 6.4 Home care – Market size and forecast 2022-2027
• Exhibit 38: Chart on Home care – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Home care – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Home care – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Home care – Year-over-year growth 2022-2027 (%)

• 6.5 Diagnostic centers – Market size and forecast 2022-2027 
• Exhibit 42: Chart on Diagnostic centers – Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Diagnostic centers – Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Diagnostic centers – Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Diagnostic centers – Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by End-user 
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

• 7.1 Market segments 
• Exhibit 48: Chart on Product – Market share 2022-2027 (%)
• Exhibit 49: Data Table on Product – Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product

• 7.3 SMBG – Market size and forecast 2022-2027
• Exhibit 52: Chart on SMBG – Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on SMBG – Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on SMBG – Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on SMBG – Year-over-year growth 2022-2027 (%)

• 7.4 CGM – Market size and forecast 2022-2027
• Exhibit 56: Chart on CGM – Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on CGM – Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on CGM – Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on CGM – Year-over-year growth 2022-2027 (%)

• 7.5 Lancets – Market size and forecast 2022-2027
• Exhibit 60: Chart on Lancets – Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Lancets – Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Lancets – Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Lancets – Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Product 
• Exhibit 64: Market opportunity by Product ($ million)
• Exhibit 65: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison

• 9.3 North America – Market size and forecast 2022-2027
• Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.4 Europe – Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.5 Asia – Market size and forecast 2022-2027
• Exhibit 79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027 
• Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027
• Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 Germany – Market size and forecast 2022-2027
• Exhibit 91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.9 UK – Market size and forecast 2022-2027
• Exhibit 95: Chart on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on UK – Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on UK – Year-over-year growth 2022-2027 (%)

• 9.10 Canada – Market size and forecast 2022-2027
• Exhibit 99: Chart on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Canada – Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Canada – Year-over-year growth 2022-2027 (%)

• 9.11 Japan – Market size and forecast 2022-2027
• Exhibit 103: Chart on Japan – Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Japan – Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Japan – Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.3 Impact of drivers and challenges 
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027

11 Vendor Landscape

• 11.2 Vendor landscape 
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 111: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 113: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 114: Matrix on vendor position and classification

• 12.3 Abbott Laboratories 
• Exhibit 115: Abbott Laboratories – Overview
• Exhibit 116: Abbott Laboratories – Business segments
• Exhibit 117: Abbott Laboratories – Key news
• Exhibit 118: Abbott Laboratories – Key offerings
• Exhibit 119: Abbott Laboratories – Segment focus

• 12.4 Ascensia Diabetes Care Holdings AG
• Exhibit 120: Ascensia Diabetes Care Holdings AG – Overview
• Exhibit 121: Ascensia Diabetes Care Holdings AG – Product / Service
• Exhibit 122: Ascensia Diabetes Care Holdings AG – Key offerings

• 12.5 Dexcom Inc. 
• Exhibit 123: Dexcom Inc. – Overview
• Exhibit 124: Dexcom Inc. – Product / Service
• Exhibit 125: Dexcom Inc. – Key news
• Exhibit 126: Dexcom Inc. – Key offerings

• 12.6 DiaMonTech AG 
• Exhibit 127: DiaMonTech AG – Overview
• Exhibit 128: DiaMonTech AG – Product / Service
• Exhibit 129: DiaMonTech AG – Key offerings

• 12.7 F. Hoffmann La Roche Ltd. 
• Exhibit 130: F. Hoffmann La Roche Ltd. – Overview
• Exhibit 131: F. Hoffmann La Roche Ltd. – Business segments
• Exhibit 132: F. Hoffmann La Roche Ltd. – Key news
• Exhibit 133: F. Hoffmann La Roche Ltd. – Key offerings
• Exhibit 134: F. Hoffmann La Roche Ltd. – Segment focus

• 12.8 GlySens Inc. 
• Exhibit 135: GlySens Inc. – Overview
• Exhibit 136: GlySens Inc. – Product / Service
• Exhibit 137: GlySens Inc. – Key offerings

• 12.9 Health Arx Technologies Pvt. Ltd. 
• Exhibit 138: Health Arx Technologies Pvt. Ltd. – Overview
• Exhibit 139: Health Arx Technologies Pvt. Ltd. – Product / Service
• Exhibit 140: Health Arx Technologies Pvt. Ltd. – Key offerings

• 12.10 Insulet Corp. 
• Exhibit 141: Insulet Corp. – Overview
• Exhibit 142: Insulet Corp. – Product / Service
• Exhibit 143: Insulet Corp. – Key news
• Exhibit 144: Insulet Corp. – Key offerings

• 12.11 Medtronic Plc 
• Exhibit 145: Medtronic Plc – Overview
• Exhibit 146: Medtronic Plc – Business segments
• Exhibit 147: Medtronic Plc – Key news
• Exhibit 148: Medtronic Plc – Key offerings
• Exhibit 149: Medtronic Plc – Segment focus

• 12.12 Medtrum Technologies Inc. 
• Exhibit 150: Medtrum Technologies Inc. – Overview
• Exhibit 151: Medtrum Technologies Inc. – Product / Service
• Exhibit 152: Medtrum Technologies Inc. – Key offerings

• 12.13 Novo Nordisk AS 
• Exhibit 153: Novo Nordisk AS – Overview
• Exhibit 154: Novo Nordisk AS – Business segments
• Exhibit 155: Novo Nordisk AS – Key offerings
• Exhibit 156: Novo Nordisk AS – Segment focus

• 12.14 Sanofi SA 
• Exhibit 157: Sanofi SA – Overview
• Exhibit 158: Sanofi SA – Business segments
• Exhibit 159: Sanofi SA – Key news
• Exhibit 160: Sanofi SA – Key offerings
• Exhibit 161: Sanofi SA – Segment focus

• 12.15 Senseonics Holdings Inc. 
• Exhibit 162: Senseonics Holdings Inc. – Overview
• Exhibit 163: Senseonics Holdings Inc. – Product / Service
• Exhibit 164: Senseonics Holdings Inc. – Key offerings

• 12.16 SFC Fluidics Inc. 
• Exhibit 165: SFC Fluidics Inc. – Overview
• Exhibit 166: SFC Fluidics Inc. – Product / Service
• Exhibit 167: SFC Fluidics Inc. – Key offerings

• 12.17 Ypsomed AG 
• Exhibit 168: Ypsomed AG – Overview
• Exhibit 169: Ypsomed AG – Business segments
• Exhibit 170: Ypsomed AG – Key offerings
• Exhibit 171: Ypsomed AG – Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 172: Inclusions checklist
• Exhibit 173: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 174: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 175: Research methodology
• Exhibit 176: Validation techniques employed for market sizing
• Exhibit 177: Information sources

• 13.5 List of abbreviations 
• Exhibit 178: List of abbreviations 

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio